| Title |
Author |
Type |
Date |
Words |
| Access Pharmaceuticals Signs US License Agreement With AMAG Pharmaceuticals For MuGard. |
|
|
Jun 10, 2013 |
755 |
| Grunenthal Group and Purdue Pharma L.P. Enter Into a Licensing Agreement. |
|
|
May 28, 2013 |
506 |
| PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry. |
|
|
May 14, 2013 |
2237 |
| PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry. |
|
|
May 13, 2013 |
2282 |
| Cempra, Inc. Signs Exclusive License and Development Agreement for Solithromycin with Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings Corporation in Japan. |
|
|
May 13, 2013 |
1006 |
| Canada : Lorus Therapeutics Signs Research and License Option Agreement with Elanco. |
|
|
Apr 18, 2013 |
269 |
| Germany : Bayer CropScience and Monsanto Enter into Cross-Licensing Agreements for Next-Generation and Enabling Technologies. |
|
|
Apr 17, 2013 |
319 |
| Bayer CropScience And Monsanto Enter Into Cross-Licensing Agreements For Next-Generation And Enabling Technologies. |
|
|
Apr 16, 2013 |
1332 |
| Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012. |
|
|
Apr 16, 2013 |
5000 |
| Shasun Pharmaceuticals Ltd and Debiopharm Group(TM) enter into licensing agreement for the manufacturing and commercialization of Huperzine-A. |
|
|
Apr 10, 2013 |
982 |
| Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs. |
|
|
Mar 28, 2013 |
825 |
| Germany : CHROMOTEK inks license deal with BAYER for high content drug profiling. |
|
|
Mar 19, 2013 |
126 |
| Turkey : Hydromer, Inc.enters into a Exclusive License Agreement with Ortopro AS for Implantable Orthopedic Devices. |
|
|
Mar 8, 2013 |
246 |
| Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies. |
|
|
Mar 6, 2013 |
542 |
| Denmark : LEO Pharma and 4SC Discovery announce exclusive research and license agreement. |
|
|
Feb 27, 2013 |
434 |
| LEO Pharma and 4SC Discovery Announce Exclusive Research and License Agreement. |
|
|
Feb 26, 2013 |
833 |
| LEO Pharma and 4SC Discovery Announce Exclusive Research and License Agreement. |
|
|
Feb 26, 2013 |
844 |
| Ventana and Biocare Medical sign p63 license agreement to aid in the differential diagnosis of benign and malignant prostate lesions. |
|
|
Feb 26, 2013 |
1118 |
| Jazz Pharmaceuticals plc and Concert Pharmaceuticals Announce Worldwide Licensing Agreement to Develop and Commercialize Deuterium-Modified Sodium Oxybate. |
|
|
Feb 26, 2013 |
1159 |
| Ligand Receives $1.4 Million Milestone Payment from Retrophin, Inc. |
|
|
Feb 25, 2013 |
812 |
| Selexis Announces Expansion of R&D License Agreement with Amgen. |
|
|
Feb 20, 2013 |
391 |
| Switzerland : Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna (imilecleucel-T) for Treatment of Multiple Sclerosis. |
|
|
Feb 6, 2013 |
387 |
| Germany : Merck and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna (imilecleucel-T) for Treatment of Multiple Sclerosis. |
|
|
Feb 6, 2013 |
379 |
| Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna(TM)(imilecleucel-T) for Treatment of Multiple Sclerosis. |
|
|
Feb 5, 2013 |
1309 |
| Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna[TM] (imilecleucel-T) for Treatment of Multiple Sclerosis. |
|
|
Feb 5, 2013 |
1883 |
| Cumberland Pharmaceuticals And PT. SOHO Industri Pharmasi enter Into Exclusive Licensing Agreement For Caldolor In Indonesia. |
|
|
Jan 29, 2013 |
1192 |
| Biotest Pharmaceuticals Announces Strategic Long-Term Manufacturing, Supply and License Agreement. |
|
|
Jan 10, 2013 |
550 |
| Pfizer Licenses Families of Spinal Muscular Atrophy Quinazoline Therapy Program. |
|
|
Jan 9, 2013 |
762 |
| Chugai and Debiopharm Group Announce an Exclusive License Agreement for Anti-Cancer Agent, FF284 (Debio 1347). |
|
|
Jan 8, 2013 |
728 |
| GlycoVaxyn AG Signs Exclusive License Agreement and Enters Research and Development Collaboration with Janssen Pharmaceuticals, Inc., to Develop Multi-Valent Bacterial Vaccine. |
|
|
Jan 4, 2013 |
540 |
| Repligen Announces Licensing Agreement with Pfizer for Spinal Muscular Atrophy Program. |
|
|
Jan 3, 2013 |
1657 |
| Microbiotix Announces Exclusive Worldwide Licensing Agreement for HCV NS5B Non-Nucleoside Polymerase Inhibitors. |
|
|
Jan 2, 2013 |
518 |
| Kobe University, KNC Laboratories and Dainippon Sumitomo Pharma in Joint-research for Anti-cancer Compound. |
|
|
Dec 30, 2012 |
287 |
| Pacira Pharmaceuticals, Inc. and Aratana Therapeutics Inc. Enter into Global Licensing Agreement for Development and Commercialization of Bupivacaine Liposome Injectable Suspension for Animal Health Indications. |
|
|
Dec 6, 2012 |
1101 |
| ThromboGenics Lands Licensing Deal of the Year at SCRIP Awards 2012. |
|
|
Nov 29, 2012 |
1097 |
| ThromboGenics Lands Licensing Deal of the Year at SCRIP Awards 2012. |
|
|
Nov 29, 2012 |
1102 |
| Arena Pharmaceuticals and Ildong Pharmaceutical Enter Into Co-Development and License Agreement for Temanogrel, a Novel Agent for Thrombotic Diseases. |
|
|
Nov 28, 2012 |
1573 |
| Cadence Pharmaceuticals Announces Settlement of OFIRMEV (Acetaminophen) Injection Patent Litigation with Perrigo Company. |
|
|
Nov 28, 2012 |
1642 |
| VTU Technology, Austria and Minapharm Pharmaceuticals S.A.E., Egypt enter into development and license agreement. |
|
|
Nov 27, 2012 |
653 |
| Unigene and Tarix Pharmaceuticals Enter Definitive Licensing Agreement for "Peptelligence-Engineered" TXA127. |
|
|
Nov 27, 2012 |
1181 |
| Research and Markets: Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2012. |
|
|
Nov 20, 2012 |
421 |
| Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development and Commercialization of a Fixed Dosed Combination of Namenda XR[R] and Donepezil for Alzheimer's Disease. |
|
|
Nov 14, 2012 |
907 |
| Colby and MannKind Sign License and Joint Development Agreement to Develop and Commercialize Cancer Immunotherapy Products. |
|
|
Nov 13, 2012 |
947 |
| LabCorp Enters Into License Agreement with Sequella for use of B-SMART[TM] Technology to develop Rapid Tuberculosis Antimicrobial Susceptibility Test. |
|
|
Oct 22, 2012 |
533 |
| Covagen enters into a strategic research collaboration and license agreement with Mitsubishi Tanabe for the development of bispecific FynomAbs. |
|
|
Oct 17, 2012 |
965 |
| Covagen enters into a strategic research collaboration and license agreement with Mitsubishi Tanabe for the development of bispecific FynomAbs. |
|
|
Oct 17, 2012 |
934 |
| Helsinn Grants Specialised Therapeutics Australia (STA) Rights to Anamorelin, a First-in-Class Compound to Treat Cachexia-Anorexia Related to Non-Small Cell Lung Cancer (NSCLC). |
|
|
Oct 15, 2012 |
1461 |
| Helsinn Grants Specialised Therapeutics Australia (STA) Rights to Anamorelin, a First-in-Class Compound to Treat Cachexia-Anorexia Related to Non-Small Cell Lung Cancer (NSCLC). |
|
|
Oct 15, 2012 |
1466 |
| AiCuris and Merck Enter Exclusive Worldwide License Agreement for Investigational Portfolio Targeting Human Cytomegalovirus. |
|
|
Oct 15, 2012 |
1167 |
| United States : PHARMACYCLICS inks strategic license deal with NOVO NORDISK. |
|
|
Oct 13, 2012 |
121 |
| United States : AstraZeneca and Ardelyx announce worldwide licensing deal for NHE3 inhibitor programme for complications of renal disease, including diabetes-induced renal disease. |
|
|
Oct 9, 2012 |
444 |
| QRxPharma Announces Strategic Collaboration with Paladin Labs. |
|
|
Oct 9, 2012 |
874 |
| Japan : Astellas Enters License Agreement with Janssen to Develop and Commercialize ASP015K, an Astellas' Oral JAK Inhibitor for Immunologic Diseases. |
|
|
Oct 3, 2012 |
309 |
| United States : DLA Piper represents Galaxy Biotech in Roche preclinical stage oncology licensing deal. |
|
|
Sep 26, 2012 |
182 |
| BioAlliance Pharma announces the execution of its licensing agreement with Vestiq Pharmaceuticals for Oravig[R] in the US. |
|
|
Sep 24, 2012 |
726 |
| Ground Communications: Oulu-based company develops a new manufacturing method for an antidiabetic drug. |
|
|
Sep 20, 2012 |
806 |
| Dyax Corp. and Kadmon Sign Strategic Licensing Agreement for DX-2400. |
|
|
Sep 20, 2012 |
1472 |
| EMD Millipore Obtains Global Licensing Agreement for induced Pluripotent Stem(iPS) Cell Patent Technology with iPS Academia Japan, Inc. (AJ). |
|
|
Sep 17, 2012 |
885 |
| United Kingdom : SUMMIT signs technology license deal with BRISTOL- MYERS SQUIBB. |
|
|
Sep 15, 2012 |
247 |
| United Kingdom : SUMMIT CORP inks Technology License Deal with BRISTOL-MYERS SQUIBB. |
|
|
Sep 14, 2012 |
101 |
| India,United Kingdom : REDX PHARMA inks licence deal with DISHMAN PHARMACEUTICALS. |
|
|
Sep 14, 2012 |
192 |
| ShangPharma and Harbour Antibodies Announce Licensing Agreement. |
|
|
Sep 13, 2012 |
819 |
| Research and Markets: Partnerships, Licensing, Investments and M&A Deals andTrends in Pharmaceuticals - Q2 2012. |
|
|
Sep 10, 2012 |
386 |
| Spain : Almirall obtains rights for Linaclotide in Mexico. |
|
|
Sep 8, 2012 |
379 |
| Finland : Lundbeck has made EUR 10 Million equity investment in Biotie and the parties amend the Selincro licensing agreement regarding territories outside the EU and US. |
|
|
Sep 8, 2012 |
483 |
| Finland : Lundbeck amends the Selincro licensing agreement ex Europe and the US and makes EUR 10 million equity investment in Biotie. |
|
|
Sep 8, 2012 |
414 |
| United States : SCYNEXIS Announces Exclusive Licensing Deal for the Treatment of Canine Dry Eye. |
|
|
Sep 5, 2012 |
447 |
| United States : VERASTEM and PFIZER enter licensing agreement for VS-6063 solid tumor therapy. |
|
Clinical report |
Sep 5, 2012 |
283 |
| SCYNEXIS[R] Announces Exclusive Licensing Deal for the Treatment of Canine Dry Eye. |
|
|
Sep 4, 2012 |
758 |
| Germany : Sangui and SastoMed Complement Licensing Agreement in View of Increasing Sales Success. |
|
|
Aug 27, 2012 |
280 |
| United States : ALEMBIC enters into license agreement with ACCU-BREAK. |
|
|
Aug 11, 2012 |
136 |
| Salix Pharmaceuticals and Alfa Wassermann Announce License Agreement for a New Extended Intestinal Release Formulation of Rifaximin. |
|
|
Aug 8, 2012 |
1585 |
| Mylan Specialty and Pfizer Announce Licensing Agreement for EpiPen Injection 0.3/0.15mg in Japan. |
|
|
Aug 7, 2012 |
1613 |
| PharmaEngine and Nanobiotix Sign Asia-Pacific Exclusive License and Collaboration Agreement For NBTXR3. |
|
Clinical report |
Aug 6, 2012 |
709 |
| Accu-Break Pharmaceuticals, Inc. Enters into a Product Development and License Agreement with Alembic Pharmaceuticals Limited. |
|
|
Aug 6, 2012 |
834 |
| Furiex Pharmaceuticals Announces Closing of Priligy[R] Asset Transfer and License Agreements. |
|
|
Jul 30, 2012 |
1108 |
| United States : MERCK inks two licensing agreements for HIV drug candidates. |
|
|
Jul 27, 2012 |
155 |
| United States : Merck Signs Two Deals for Novel HIV Drug Candidates and Initiates Phase II Clinical Trial of MK-1439 for HIV. |
|
|
Jul 25, 2012 |
414 |
| Merck Signs Two Deals for Novel HIV Drug Candidates and Initiates Phase II Clinical Trial of MK-1439 for HIV. |
|
|
Jul 24, 2012 |
912 |
| BioAlliance Pharma announces a license agreement on Oravig[R] In the United States with Vestiq Pharmaceuticals. |
|
|
Jul 19, 2012 |
761 |
| RegeneRx and Lee's Pharmaceutical (HK) Complete License Agreement for Development of RegeneRx Product Candidates in China (including Hong Kong and Macau) and Taiwan. |
|
|
Jul 16, 2012 |
1290 |
| PDS Biotechnology Corporation Signs Worldwide Licensing Agreement with Merck KGaA for Versamune(TM). |
|
|
Jul 9, 2012 |
421 |
| PDS Biotechnology Corporation Signs Worldwide Licensing Agreement with Merck KGaA for Versamune(TM). |
|
|
Jul 9, 2012 |
427 |
| Navidea Biopharmaceuticals Elects to Extend Evaluation Period for Option to License Parkinson's Disease Imaging Agent. |
|
|
Jun 26, 2012 |
765 |
| Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement. |
|
|
Jun 18, 2012 |
588 |
| Israel : BioAlliance Pharma inks exclusive license deal with Abic Marketing. |
|
|
Jun 15, 2012 |
155 |
| BioAlliance Pharma and Teva Announce First License Agreement for Sitavig[R] for Israel. |
|
|
Jun 13, 2012 |
829 |
| Ventana signs exclusive licensing agreement for the commercialization of a novel BRAF V600E mutation antibody for cancer detection. |
|
|
May 31, 2012 |
1128 |
| Research and License Agreements between National Cheng Kung University and Novo Nordisk A/S. |
|
|
May 15, 2012 |
382 |
| Late-Stage Drugs Are Hotbed for Co-Development and Licensing Deals. |
|
|
May 14, 2012 |
426 |
| Furiex Pharmaceuticals and Menarini Announce License Agreement for Priligy[R]. |
|
|
May 14, 2012 |
1161 |
| SK Biopharmaceuticals Enters into a Licensing Agreement with Hanmi Pharmaceutical. |
|
Company overview |
May 9, 2012 |
797 |
| POZEN Announces Licensing Deal with Desitin Arzneimittel GMBH for MT 400 Migraine Treatment in 29 European Countries. |
|
|
May 8, 2012 |
1072 |
| Ajinomoto Pharmaceuticals/Albireo Sign License Pact. |
|
|
May 1, 2012 |
740 |
| Caisson Biotech Enters into Development and License Agreement with Novo Nordisk. |
|
|
May 1, 2012 |
738 |
| Tolero and MannKind Sign Collaboration and License Agreement to Develop and Commercialize Novel BTK Inhibitors for Hematological Malignancies and Inflammatory Diseases. |
|
|
Apr 30, 2012 |
826 |
| Cannabis Science Signs Andrew Pitsicalis as International Brand and Licensing Director, Rockin Artwork Grants Cannabis Science a License to Make Jimi Hendrix Image and Likeness Related Products for Advertising, Manufacturing, Sales and Marketing. |
|
|
Apr 20, 2012 |
802 |
| Eisai Amends License Agreement With Teikoku Pharma USA For Aricept[R] Patch (Donepezil Transdermal System). |
|
|
Apr 20, 2012 |
512 |
| Dyax and Eclipse Therapeutics Announce Oncology Antibody License Agreement. |
|
|
Apr 17, 2012 |
1186 |
| Life sciences team oversees a pounds 56m licence agreement. |
|
|
Apr 5, 2012 |
279 |
| Ajinomoto Pharmaceuticals and Albireo Announce Japan and Asia License Agreement for Elobixibat. |
|
|
Apr 3, 2012 |
868 |
| Eisai and Minophagen Pharmaceutical Conclude License Agreement Concerning the Development and Commercialization of Cutaneous T-Cell Lymphoma Treatment Bexarotene in Asia, Oceania, the Middle East and Eastern Europe. |
|
|
Apr 2, 2012 |
506 |
| GE Healthcare and Dyax Announce Licensing Agreement for c-Met Imaging Peptides for Use in Colorectal, Lung and Liver Cancer Research. |
|
|
Mar 31, 2012 |
800 |
| Optimer Pharmaceuticals, Inc. and Astellas Pharma Inc. Enter Collaboration to Commercialize Fidaxomicin for Clostridium difficile Infection in Japan. |
|
|
Mar 29, 2012 |
1379 |
| Urological Disorders Therapeutics to 2017 - Large Number of Licensing Deals for Approved Products Reflects a Pessimistic R&D Future. |
|
|
Mar 28, 2012 |
5094 |
| Allena Pharmaceuticals Licenses Worldwide Rights to Hyperoxaluria Portfolio from Althea Technologies. |
|
|
Mar 28, 2012 |
920 |
| RegeneRx and Lee's Pharmaceutical (HK) Sign Term Sheet for Development of RegeneRx Product Candidates in China, Hong Kong and Macau. |
|
|
Mar 27, 2012 |
1289 |
| Pharma and Biotech Licensing Deals Cost up to $8 Million to Complete, Finds Cutting Edge Information. |
|
|
Mar 26, 2012 |
419 |
| Avanir Pharmaceuticals and Concert Pharmaceuticals Announce License Agreement to Develop and Commercialize Deuterium-modified Dextromethorphan for Disorders of the Nervous System. |
|
|
Feb 29, 2012 |
1055 |
| Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China. |
|
|
Feb 28, 2012 |
1380 |
| Arno Therapeutics Announces Exclusive Licensing Agreement with Invivis Pharmaceuticals to Develop Cancer Drug. |
|
|
Feb 14, 2012 |
647 |
| Bend Research Signs License Agreement With Eli Lilly and Company. |
|
|
Feb 8, 2012 |
447 |
| Isotechnika Enters Into Development With Vifor Pharma. |
|
|
Jan 31, 2012 |
533 |
| Antares Pharma Enters Licensing Agreement with Daewoong Pharmaceuticals Co. Ltd. for Oxybutynin Gel 3% in South Korea. |
|
|
Jan 17, 2012 |
1348 |
| LEO Pharma A/S In-Licenses Promising Compound From Virobay Inc. for Oral Treatment of Psoriasis. |
|
|
Jan 9, 2012 |
786 |
| Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine. |
|
|
Jan 6, 2012 |
572 |
| Antares Pharma Enters Licensing Agreement with Pfizer Consumer Healthcare. |
|
|
Dec 20, 2011 |
771 |
| Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt(TM) in Israel. |
|
|
Dec 13, 2011 |
1115 |
| Merganser Biotech Announces Signing of Option to License Minihepcidin Technology from UCLA. |
|
|
Dec 12, 2011 |
745 |
| Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765. |
|
|
Dec 8, 2011 |
727 |
| Lonza forms manufacturing license agreement with Sumitomo Seika Chemicals. |
|
|
Dec 1, 2011 |
153 |
| Astellas Pharma Europe Ltd Wins Award for Licensing Deal. |
|
|
Dec 1, 2011 |
704 |
| Research and Markets: Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2011. |
|
|
Nov 23, 2011 |
486 |
| Bend Research Signs Technology Licensing Agreement with Merck. |
|
|
Nov 14, 2011 |
390 |
| Daiichi Sankyo To License ARQ 092 from ArQule, the First New Compound Resulting from the Companies' Joint AKIP Research Collaboration. |
|
|
Nov 10, 2011 |
1128 |
| Astellas Pharma Europe Ltd Wins Scrip Award for Licensing Deal of the Year. |
|
|
Nov 4, 2011 |
819 |
| ATLAB Pharma and BZL Biologics Announce Exclusive Global Licensing Agreement for Lu-J591, a Novel Radiopharmaceutical in Phase IIB for the Treatment of Prostate Cancer. |
|
Clinical report |
Oct 28, 2011 |
648 |
| Marshall Edwards and Ausio Pharmaceuticals Announce Exclusive License Agreement. |
|
|
Oct 27, 2011 |
885 |
| Acton Pharmaceuticals, Inc. Announces License Agreement with Sanofi U.S. for NASACORT HFA[TM] (triamcinolone acetonide) Nasal Aerosol. |
|
|
Oct 25, 2011 |
1073 |
| Ligand Enters into Platform Captisol[R] License Agreement with SAGE Therapeutics. |
|
|
Oct 19, 2011 |
1130 |
| Asahi Kasei Licenses Zosano Pharma Microprojection Technology for Teribone Hormone. |
|
|
Oct 17, 2011 |
146 |
| Roche Licenses Nanopore Sequencing Technologies from Arizona State University and Columbia University for Rapid, Affordable DNA Sequencing. |
|
|
Oct 11, 2011 |
1031 |
| Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn[R]. |
|
|
Oct 10, 2011 |
1326 |
| Pfizer Announces Licensing Agreement With Puma Biotechnology, Inc. For The Development And Commercialization Of Neratinib, An Investigational Pan-HER Inhibitor. |
|
|
Oct 5, 2011 |
827 |
| Gilead and Boehringer Ingelheim Sign License Agreement for Novel HIV Non-Catalytic Integrase Inhibitors. |
|
|
Oct 5, 2011 |
808 |
| Mylan Announces XELODA Settlement and License Agreement. |
|
|
Sep 21, 2011 |
410 |
| Aestus Therapeutics and Prosidion Ltd Sign License Agreement for Novel Chronic Pain Therapeutic. |
|
|
Sep 19, 2011 |
849 |
| Hawthorn Pharmaceuticals announce Alzheimer's Global Licensing Deal with CoPlex Therapeutics. |
|
|
Sep 12, 2011 |
491 |
| CorMedix Announces Amended Agreement for CRMD001 (A Proprietary Formulation of Deferiprone). |
|
|
Sep 6, 2011 |
772 |
| Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Biotoscana Farma S.A. for Commercialization of Fanapt (TM) in Argentina. |
|
|
Aug 1, 2011 |
1085 |
| Ironwood Pharmaceuticals and Depomed Announce Collaboration, Research and License Agreement. |
|
|
Jul 27, 2011 |
789 |
| Dyax Corp. and Kadmon Corporation Announce Antibody Library License Agreement. |
|
|
Jul 26, 2011 |
1105 |
| BioSante Pharmaceuticals Signs Melanoma Vaccine License. |
|
|
Jul 21, 2011 |
983 |
| CEL-SCI Corporation and Teva Pharmaceuticals Expand Licensing Agreement. |
|
|
Jul 19, 2011 |
633 |
| Gilead Expands Access Program for Medications in Developing World. |
|
|
Jul 12, 2011 |
1494 |
| Cannabis Science Signs A New Non-Exclusive Commercial License Agreement with Rockbrook To Continue Its Strategic Partnership In The State Of Colorado. |
|
|
Jul 12, 2011 |
480 |
| Bristol-Myers Squibb and Innate Pharma Announce Breakthrough Global License Agreement for an Investigational Immuno-Oncology Biologic. |
|
|
Jul 6, 2011 |
1156 |
| Valeant Pharmaceuticals Announces License Agreement With Meda for North American Rights for Elidel and Xerese(TM). |
|
|
Jun 30, 2011 |
761 |
| BioLineRx Signs Exclusive License Agreement with Yissum for Oral Phase II Ready Treatment BL-7040 for Inflammatory Bowel Disease. |
|
|
Jun 27, 2011 |
1172 |
| Vertex and Alios BioPharma Announce Exclusive Worldwide Licensing Agreement for Two Nucleotide Drug Candidates, Broadening Vertex's Efforts to Develop New Combinations of Medicines for Hepatitis C. |
|
|
Jun 13, 2011 |
2734 |
| Ligand and The Medicines Company Agree to Worldwide License for Proprietary Captisol[R]-Enabled Intravenous Formulation of Clopidogrel. |
|
|
Jun 3, 2011 |
1298 |
| AVEO Pharmaceuticals Enters into Worldwide License Agreement with Centocor Ortho Biotech to Develop and Commercialize RON-Targeted Antibodies. |
|
|
May 31, 2011 |
1063 |
| Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze (C1 esterase inhibitor [human]). |
|
|
May 11, 2011 |
1536 |
| Allergan and Molecular Partners Enter into an Exclusive License Agreement For MP0112 For the Treatment of Retinal Diseases. |
|
|
May 4, 2011 |
1137 |
| Flamel Technologies Announces Micropump[R] License Agreement; $3 Million Upfront Payment. |
|
|
Apr 28, 2011 |
411 |
| IRIS Pharma and OPIA Technologies Announce Licence Agreement. |
|
|
Apr 26, 2011 |
596 |
| Kadmon Pharmaceuticals and Nano Terra Announce Worldwide Exclusive Licensing Agreement for Three Novel Product Candidates. |
|
|
Apr 25, 2011 |
830 |
| Forest Laboratories and Blue Ash Therapeutics Enter Into Asset Purchase Agreement for Azimilide, a Novel Phase III Antiarrhythmic Agent. |
|
|
Apr 19, 2011 |
846 |
| Helsinn and Taiho Pharmaceutical Co., Ltd. to Extend Relationship. |
|
|
Apr 13, 2011 |
981 |
| Cubist Pharmaceuticals Settles CUBICIN Patent Litigation with Teva. |
|
|
Apr 4, 2011 |
1759 |
| R-Tech Ueno: Announcement of the Execution of a License Agreement for Unoprostone. |
|
|
Mar 23, 2011 |
1309 |
| POZEN Announces Licensing Deal with Cilag GmbH, A Division of Johnson & Johnson, for MT 400, Migraine Treatment. |
|
|
Mar 23, 2011 |
1357 |
| Nerviano Medical Sciences Announces New License Agreement. |
|
|
Mar 15, 2011 |
294 |
| MBL Signs Non-Exclusive License With Envoy Therapeutics for Access to RIP-Chip Technology. |
|
|
Mar 15, 2011 |
460 |
| RaQualia and Aratana Therapeutics Sign Animal Health Licensing Agreement. |
|
|
Mar 4, 2011 |
389 |
| BioAlliance Pharma: Consolidated Turnover for 2010 Exceptional Performance Linked to International Licensing Agreements. |
|
|
Feb 10, 2011 |
997 |
| Salix Pharmaceuticals and Progenics Pharmaceuticals Announce Worldwide License Agreement for RELISTOR[R]. |
|
|
Feb 7, 2011 |
2091 |
| Progenics Pharmaceuticals and Salix Pharmaceuticals Announce Worldwide License Agreement for RELISTOR[R]. |
|
|
Feb 7, 2011 |
2095 |
| Neuro-Biotech Pursues the Implementation of its Licensees Network and Signs a LOI with Israel. |
|
|
Jan 25, 2011 |
414 |
| Astellas Enters Into License Agreement With TOLMAR. |
|
|
Jan 17, 2011 |
372 |
| Celsion Corporation Announces Convertible Preferred Stock Financing and Amended License Agreement for Aggregate Gross Proceeds of up to $9 Million. |
|
|
Jan 13, 2011 |
1163 |
| Biotechnology company Xoma Ltd (Berkeley CA) said it signed a development and licensing deal with Les Laboratoires Servier (Neuilly-sur-Seine FRA) potentially worth more than $500 million for an anti-inflammatory drug candidate. |
|
|
Jan 10, 2011 |
200 |
| Takeda and Zinfandel Pharmaceuticals Sign Licensing Agreement for Alzheimer's Disease Biomarker in Combination with Pioglitazone. |
|
|
Jan 10, 2011 |
595 |
| Kiadis Pharma Signs License Agreement With Hospira to Commercialize ATIR(TM) in Europe and Asia. |
|
|
Jan 4, 2011 |
714 |
| Kiadis Pharma Signs License Agreement with Hospira to Commercialize ATIR[TM] in Europe and Asia. |
|
|
Jan 4, 2011 |
691 |
| Clinical Data, Inc. Receives Notice of IND Filing by Santen and Upcoming Milestone Payment for A2A Agonist Development Program Focused on Glaucoma Treatments. |
|
|
Dec 22, 2010 |
1282 |
| AstraZeneca and Abbott End License Agreement for the Development of CERTRIAD. |
|
|
Dec 22, 2010 |
293 |
| Novo Nordisk A/S and Emisphere Technologies, Inc. Announce License Agreement to Develop Oral Formulation of Insulin for Diabetes. |
|
|
Dec 21, 2010 |
553 |
| Bristol-Myers Squibb and Oncolys BioPharma Enter Global Licensing Agreement for Investigational HIV Compound. |
|
|
Dec 20, 2010 |
704 |
| 3M Drug Delivery Systems Signs Licensing Agreement with Spirig Pharma AG. |
|
|
Dec 16, 2010 |
586 |
| Serodus AS Licenses Compound from Roche for Potential Treatment of Heart Failure. |
|
|
Dec 10, 2010 |
428 |
| Forest Laboratories and Gruenenthal Enter Into Licensing Agreement for the Development and Commercialization of Novel Analgesic Compound. |
|
|
Dec 6, 2010 |
782 |
| Amsterdam Molecular Therapeutics Amends Amgen GDNF Gene License Agreement. |
|
|
Dec 2, 2010 |
640 |
| SINCLAIR PHARMA PLC - Licence agreement with Medpharm for Terbinafine Spray. |
|
Company overview |
Dec 2, 2010 |
1087 |
| Ascenta Therapeutics and Ascentage Pharma Sign R&D Collaboration and Regional License Agreements for Two Cancer Programs. |
|
|
Dec 1, 2010 |
789 |
| CVBT Licenses Phase II Diabetic Wound Healing Data From Merck. |
|
|
Nov 30, 2010 |
603 |
| Nostrum Pharmaceuticals, LLC Licenses Clinical Development and Worldwide Commercialization Rights From IMTECH, India, for Novel, Next-Generation Thrombolytics With Clot Specific Activation and Re-occlusion Prevention Properties. |
|
|
Nov 24, 2010 |
864 |
| Omni Bio Pharmaceutical, Inc. Awarded Patent for Treating and Preventing Viral Infection. |
|
|
Nov 23, 2010 |
1094 |
| Laboratorios SALVAT, S.A. and Kwang Dong Pharmaceutical Co., LTD Announce a Development and Licensing Agreement for Tarafenacin in the Treatment of Overactive Bladder. |
|
|
Nov 17, 2010 |
526 |
| Protein Sciences Expands License Agreement with UMN Pharma. |
|
|
Nov 9, 2010 |
581 |
| SurModics and Edge Therapeutics Collaborate on Development of Sustained-Release Neurological Product. |
|
|
Nov 3, 2010 |
1364 |
| MingSight Signs Licensing Agreement with Pfizer. |
|
|
Oct 11, 2010 |
407 |
| Teva and OncoGenex Announce Initiation of Second Phase 3 Trial of Custirsen in Men with Metastatic Prostate Cancer. |
|
|
Sep 30, 2010 |
1756 |
| Brain Factory and Eisai Conclude License Agreement for Ravuconazole Prodrug. |
|
|
Sep 30, 2010 |
539 |
| NanoBio[R] Awarded Licensing Executive Society's "Deal of Distinction" for Licensing Agreement with GlaxoSmithKline. |
|
|
Sep 29, 2010 |
430 |
| SP Scientific Signs License Agreement for Praxair's ControLyo[TM] Nucleation Technology. |
|
|
Sep 29, 2010 |
480 |
| Moffitt Cancer Center and GLG Pharma, LLC Sign Licensing Agreement. |
|
|
Sep 16, 2010 |
658 |
| Asklepios BioPharmaceutical Enters Into A Patent License Agreement With Pfizer. |
|
|
Sep 13, 2010 |
284 |
| Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET. |
|
|
Sep 8, 2010 |
2039 |
| Concordia Pharmaceuticals, Inc. Signs First Licensing Agreement with Ono Pharmaceutical Co, Ltd. for Salirasib. |
|
|
Sep 1, 2010 |
518 |
| Pharma-Biotech Licensing Deals -- Stopgap Option or Way of the Future? -- Frost & Sullivan Web Conference. |
|
Conference news |
Aug 26, 2010 |
476 |
| Pharma-Biotech Licensing Deals -- Stopgap Option or Way of the Future? -- Frost & Sullivan Web Conference. |
|
Conference news |
Aug 26, 2010 |
632 |
| Research and Markets: Pharmaceutical Licensing Overview - Includes Assessment of Drug Discovery & Technology Deals Made by the Top 10 Pharma Companies. |
|
|
Aug 11, 2010 |
489 |
| Document Security Systems, Inc. Signs Licensing Agreement with Pharmaceutical Label Manufacturer. |
|
|
Aug 4, 2010 |
1326 |
| Targacept Makes Strategic Additions to Inflammatory Disorders Program. |
|
|
Aug 3, 2010 |
1004 |
| Osteologix and Servier Announce ex-US Licensing Agreement. |
|
|
Aug 2, 2010 |
1096 |
| Cornerstone Therapeutics Announces Collaboration with The Cough Company. |
|
|
Aug 2, 2010 |
902 |
| Optimer Pharmaceuticals Receives Milestone Payment From Cempra for Next-Generation Macrolide Antibiotic. |
|
|
Jul 8, 2010 |
934 |
| SurModics Signs License Agreement with Clinuvel Pharmaceuticals. |
|
|
Jul 7, 2010 |
1150 |
| X-Chem and Roche Enter Into Drug Discovery Collaboration and License Agreement. |
|
|
Jul 1, 2010 |
308 |
| Sanofi may pay over $1 billion in new licensing deals. Sanofi-Aventis SA. |
|
|
Jun 28, 2010 |
281 |
| Marinomed Signs Collaboration with Boehringer Ingelheim for Anti-Viral Nasal Spray against Common Cold. |
|
|
Jun 28, 2010 |
577 |
| Aestus Therapeutics and Astellas Pharma Sign License Deal for Novel Chronic Pain Therapeutic. |
|
|
Jun 28, 2010 |
373 |
| LILLY (ELI) & COMPANY - Marcadia - Lilly Novel Glucagon Program. |
|
|
Jun 28, 2010 |
583 |
| Transdel Pharmaceuticals Enters into License Agreement with Jan Marini Skin Research for Cosmeceutical Product. |
|
|
Jun 17, 2010 |
950 |
| Alnylam Secures Intellectual Property and Technology for RNAi Applications in Vaccine Research and Development. |
|
|
Jun 17, 2010 |
1064 |
| Tranzyme Pharma and Norgine Sign License Agreement for Late-Stage Development Product, Ulimorelin (TZP-101), in Europe and Other Select Regions. |
|
|
Jun 16, 2010 |
669 |
| Forest Laboratories and TransTech Pharma Enter Into License Agreement for the Development and Commercialization of Glucokinase Activators with Deal Valued at Up to $1.105 Billion. |
|
|
Jun 8, 2010 |
923 |
| Acella Pharmaceuticals Signs License Agreement for U.S. Marketing Rights to Generic Antibiotic. |
|
|
Jun 7, 2010 |
166 |
| Biovail Corp (Mississauga, Ontario) said Thursday it signed a license agreement with Kyowa Hakko Kirin Co Ltd for US and Canadian rights to products containing a chemical aimed at treating Parkinson's disease. |
|
|
Jun 7, 2010 |
106 |
| Biovail Enters into License Agreement with Kyowa Hakko Kirin. |
|
|
Jun 3, 2010 |
1086 |
| Hawthorn Pharmaceuticals and the University of Pittsburgh Sign Exclusive Global Licensing Agreement of CSPG4 Specific Monoclonal Antibodies. |
|
|
May 17, 2010 |
361 |
| SmartOps Continues To Solidify Market Leadership Position In Supply Chain Optimization Through New Licensing Agreements. |
|
|
May 12, 2010 |
346 |
| SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd. |
|
|
May 6, 2010 |
665 |
| Clinical Data, Inc. Licenses Adenosine A2A Agonist to Santen for Development of Ophthalmic Treatments. |
|
|
May 3, 2010 |
1411 |
| Digimarc and AlpVision Join Forces with Worldwide Strategic License Agreement. |
|
|
Apr 30, 2010 |
624 |
| Synergetics USA Enters into a Settlement and License Agreement with Alcon. |
|
|
Apr 27, 2010 |
490 |
| AVEO Pharmaceuticals Receives Milestone Payment from Biogen Idec under Licensing Agreement for ErbB3 Antibody Program. |
|
|
Apr 14, 2010 |
970 |
| HemCon Medical Technologies, Inc. and Zeria Pharmaceuticals Co. Ltd. Sign Exclusive Licensing Agreement for HemCon's Innovative Product Line in Japan. |
|
|
Apr 9, 2010 |
440 |
| NanoMaterials Technology Signs Exclusive Licensing Agreement for Hyperlipidemia-controlling Drug with Beijing Winsunny Pharmaceutical. |
|
|
Apr 8, 2010 |
683 |
| Cord Blood America Signs License Agreement to Operate Stem Cell Collection Business in China. |
|
|
Mar 31, 2010 |
1027 |
| TRANSITION THERAPEUTICS SIGNS LICENSING PACT WITH LILLY. |
|
|
Mar 30, 2010 |
424 |
| Rigel Announces Expiry of Waiting Period Under Hart-Scott-Rodino Act for Licensing Agreement With Astrazeneca. |
|
|
Mar 29, 2010 |
750 |
| Eli Lilly & Co. |
|
Brief article |
Mar 22, 2010 |
236 |
| An experimental blood thinner being developed by Merck & Co (Whitehouse Station NJ) from a new class of drugs appeared to be safe and effective in a mid-stage study that compared three doses against widely used warfarin in patients with atrial fibrillation. |
|
|
Mar 22, 2010 |
322 |
| Solasia Pharma and Kyowa Hakko Kirin Enter Into a License Agreement for SP-01 (Sancuso[R]) in Asia. |
|
|
Mar 3, 2010 |
478 |
| Shionogi Enters into Exclusive License Agreement with QuatRx Pharmaceuticals to Market Ospemifene. |
|
|
Mar 2, 2010 |
1076 |
| Derma Sciences Finalizes Licensing Agreement for Worldwide Rights to MEDIHONEY(R). |
|
|
Feb 25, 2010 |
1172 |
| New drug class offers hope against "superbugs". |
|
|
Feb 22, 2010 |
324 |
| Astra paying over $2 billion for Rigel arthritis drug. AstraZeneca Plc. |
|
|
Feb 22, 2010 |
394 |
| AstraZeneca and Rigel Pharmaceuticals Sign Worldwide License Agreement for Late-Stage Development Product -- Fostamatinib Disodium (R788) -- for the Treatment of Rheumatoid Arthritis (RA). |
|
|
Feb 16, 2010 |
2452 |
| Cannabis Science Inc. (CBIS) Announces Progress in Bringing the First Cannabis Based Medicine to Market Company moving towards contracts and licensing agreements for research and development of new medicines. |
|
|
Feb 9, 2010 |
349 |
| Trillium and Biogen Idec Enter Into Global License Agreement. |
|
|
Jan 12, 2010 |
506 |
| EpiCept Announces Commercial Licensing Agreement for Ceplene[R] with Meda in Europe and Pacific Rim. |
|
|
Jan 11, 2010 |
1276 |
| Cannabis Science Outlines Objectives For The New Year; Highlights Include Moving Towards Contracts and Licensing Agreements For Research and Development of New Medicines. |
|
|
Jan 11, 2010 |
516 |
| Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex' Late Stage Innovative Treatment for Multiple Oncology Indications. |
|
|
Dec 21, 2009 |
1914 |
| Neurowave Medical Technologies[TM] LLC and Alaven[R] Pharmaceutical LLC Announce Licensing Agreement for Medical Device for the Treatment of Pregnancy Related Nausea and Vomiting (NVP). |
|
|
Dec 17, 2009 |
720 |
| Xencor Receives Milestone Payment from Pfizer Under Antibody Technology License Agreement. |
|
|
Dec 16, 2009 |
284 |
| Licensing Executives Society (USA & Canada) Warns That Healthcare Reform Could Make the Patient Sicker. |
|
|
Dec 15, 2009 |
1075 |
| Pacific Beach BioSciences Signs Agreement with Pharma Company for Compound Required for Manufacturing of Clinical Stage Product. |
|
|
Dec 9, 2009 |
384 |
| Astra buys rights to Targacept drug. |
|
Brief article |
Dec 7, 2009 |
307 |
| Mintz Levin Intellectual Property Practice Represents Protalix in $60 Million Licensing Agreement with Pfizer Inc. |
|
|
Dec 4, 2009 |
232 |
| AstraZeneca and Targacept Form Global Collaboration and License Agreement for Late-stage Investigational Product TC-5214 for the Treatment of Major Depressive Disorder. |
|
|
Dec 3, 2009 |
1463 |
| Incyte Announces Major Collaboration and License Agreement for Two Hematology-Oncology Programs. |
|
|
Nov 25, 2009 |
1024 |
| Appian Labs Announces Development and Commercial License Agreement with Capsugel for the AppiForm[TM] Modular Release System. |
|
|
Nov 17, 2009 |
548 |
| BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of Therapeutic Antibodies. |
|
|
Nov 13, 2009 |
510 |
| Flamel Technologies Announces Licensing Agreement with Pfizer. |
|
|
Nov 4, 2009 |
420 |
| Ligand Updates License Agreement with Exelixis. |
|
|
Nov 2, 2009 |
537 |
| SurModics and NuPathe Partner to Develop Novel Long-Acting Parkinson's Treatment. |
|
|
Nov 2, 2009 |
996 |
| Hercules Technology Growth Capital Announces Three Portfolio Companies That Reached Multi-Million Dollar Milestones. |
|
|
Oct 20, 2009 |
1149 |
| Mintz Levin Represents Paratek Pharmaceuticals, Inc. in $485M Licensing Agreement With Novartis. |
|
|
Oct 14, 2009 |
236 |
| Santarus and Norgine Enter License for ZEGERID Immediate-Release Omeprazole Products in Europe. |
|
|
Oct 12, 2009 |
974 |
| Kyorin and Eisai Sign License Agreement for Development and Marketing of Uritos(R) Tablets in China, India, Sri Lanka and ASEAN Countries. |
|
|
Sep 29, 2009 |
470 |
| KYORIN and Eisai Sign License Agreement for Development and Marketing of Uritos(R) Tablets in China, India, Sri Lanka and ASEAN Countries. |
|
|
Sep 29, 2009 |
549 |
| Eisai and DNDi Enter Collaboration and License Agreement to Develop New Drug for Chagas Disease. |
|
|
Sep 29, 2009 |
990 |
| Nektar Therapeutics Inc. |
|
Brief article |
Sep 28, 2009 |
128 |
| Rexahn Pharmaceuticals and Teva Pharmaceutical Industries Close on a License Agreement. |
|
|
Sep 21, 2009 |
505 |
| Rexahn Pharmaceuticals and Teva Pharmaceutical Industries Agree to Close on a License Agreement. |
|
|
Sep 17, 2009 |
675 |
| Dyax Announces Developments in Licensing and Funded Research Program. |
|
|
Aug 26, 2009 |
1183 |
| Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market and Distribute Cobroxin, a Treatment for Chronic Pain. |
|
|
Aug 26, 2009 |
699 |
| Transcept Pharmaceuticals Inc. |
|
Brief article |
Aug 10, 2009 |
147 |
| Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305. |
|
|
Aug 6, 2009 |
1250 |
| Ligand and Organon Mutually Terminate Collaboration and License Agreement. |
|
|
Jul 30, 2009 |
655 |
| Eisai Signs License Agreement with Biocompatibles International for Drug-Eluting Bead Products for Embolisation. |
|
|
Jul 28, 2009 |
634 |
| Hercules Technology Growth Capital Announces Successful Fund Raising Activities from Select Life Sciences Portfolio Companies Despite Challenging Economy. |
|
|
Jul 27, 2009 |
877 |
| Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc. |
|
|
Jul 16, 2009 |
481 |
| AstraZeneca cancels deal on MAP Pharma's asthma drug. |
|
Brief article |
Jul 13, 2009 |
241 |
| Targacept Inc. |
|
Brief article |
Jul 13, 2009 |
257 |
| Merck & Co., Inc. and Portola Enter Worldwide License Agreement to Develop and Commercialize Betrixaban, a Novel Investigational Oral Anticoagulant for Cardiovascular Disease. |
|
|
Jul 9, 2009 |
1150 |
| Laboratorios SALVAT, S.A. and WraSer Pharmaceuticals, LLC Announce Exclusive License Agreement for the Commercialization of CETRAXAL[R] (ciprofloxacin otic solution) 0.2%. |
|
|
Jul 8, 2009 |
456 |
| Watson Pharmaceuticals Inc. (Corona CA) won approval to sell the first generic copy of Plan B, the emergency contraceptive made by Israel's Teva Pharmaceutical Industries Ltd. |
|
Brief article |
Jun 29, 2009 |
253 |
| Rexahn Pharmaceuticals Signs Development and Commercialization Agreement with a Top 20 Pharmaceutical Company for Novel Anti-cancer Compound. |
|
|
Jun 29, 2009 |
624 |
| Arrowhead Subsidiary Calando Pharmaceuticals Enters into License Agreement with Cerulean Pharma Inc. |
|
|
Jun 23, 2009 |
958 |
| Cerulean Pharma Inc. Announces License Agreement with Calando Pharmaceuticals, Inc., a Subsidiary of Arrowhead Research Corporation. |
|
|
Jun 23, 2009 |
609 |
| Covidien Plc. |
|
Brief article |
Jun 22, 2009 |
195 |
| NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM). |
|
|
Jun 22, 2009 |
1529 |
| Antibiotic's $1 billion success may spur cubist buy; analysts. |
|
|
Jun 1, 2009 |
343 |
| Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd. |
|
|
May 26, 2009 |
485 |
| Pfizer Expands Its Generics Portfolio Through Innovative Licensing Deals, Increasing Access To Medicines For Billions Worldwide. |
|
|
May 20, 2009 |
873 |
| Solvay Pharmaceuticals, Inc. Licenses Exclusive Development and Commercial Rights to Oral Testosterone Formulation from Lipocine Inc. |
|
|
May 19, 2009 |
501 |
| SymBio Pharmaceuticals Limited and Eisai Co., Ltd. Conclude License Agreement for Bendamustine Hydrochloride (SyB L-0501) in Korea and Singapore. |
|
|
May 18, 2009 |
649 |
| Medtronic Inc. (Minneapolis MN) said it paid Johnson & Johnson (New Brunswick NJ) $270 million to settle outstanding royalty disputes between the medical device companies involving 1997 license agreements on artery clearing angioplasty stent and balloon patents. |
|
Brief article |
May 18, 2009 |
125 |
| Nycomed A/S hopes to pick a U.S. licensing partner for Daxas, its "smoker's lung" drug, by the end of June and ultimately aims for a stock market listing, the privately held Swiss drugmaker said. |
|
Brief article |
May 11, 2009 |
286 |
| Biovail Enters into Collaboration and License Agreement with Acadia for Pimavanserin. |
|
|
May 4, 2009 |
1032 |
| Financing: Oxford BioMedica Plc said French drugmaker Sanofi Aventis SA had handed back rights to Trovax, a therapeutic cancer vaccine, to the biotech company but also started a new alliance in eye medicine. |
|
Brief article |
May 4, 2009 |
171 |
| Merck & Co., Inc. and Cardiome Pharma Corp. sign a collaboration and license agreement for the development and commercialization of vernakalant, an investigational candidate for the treatment of atrial fibrillation. |
|
|
May 1, 2009 |
98 |
| Neuromed announces that Merck & Co., Inc. terminates research collaboration and license agreement for compounds targeting N-type calcium channels. |
|
|
May 1, 2009 |
270 |
| NextBio Announces Licensing Agreement with Merck & Co., Inc. |
|
|
Apr 27, 2009 |
267 |
| Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection. |
|
|
Apr 21, 2009 |
1663 |
| StemCells, Inc. Announces License Agreement with Major Pharmaceutical Company Covering Gene Insertion Technology. |
|
|
Apr 16, 2009 |
812 |
